[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

OCUL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.50%

Insider Buying (Last 12 Months): $24,765.00

Insider Selling (Last 12 Months): $165,878.96

Ocular Therapeutix Insider Trading History Chart

Ocular Therapeutix Share Price & Price History

^$2.29

▲ +0.06 (2.69%)

As of 11/28/2023 01:00 AM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

Ocular Therapeutix Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/30/2023	Antony C. Mattessich	CEO	Buy	6,500	$3.81	$24,765.00	6,500
7/7/2023	Rabia Gurses Ozden	Insider	Sell	832	$4.93	$4,101.76	100,531
2/6/2023	Antony C. Mattessich	CEO	Sell	19,669	$4.24	$83,396.56	446,281
2/6/2023	Christopher G White	Insider	Sell	5,829	$4.24	$24,714.96	94,766
2/6/2023	Donald Notman	CFO	Sell	6,476	$4.24	$27,458.24	139,387
2/6/2023	Philip C Strassburger	General Counsel	Sell	6,181	$4.24	$26,207.44	109,071
11/7/2022	Summer Road Llc	Major Shareholder	Buy	7,328	$3.50	$25,648.00	6,122,089
10/10/2022	Summer Road Llc	Major Shareholder	Buy	10,000	$4.00	$40,000.00	6,104,761
9/29/2022	Summer Road Llc	Major Shareholder	Buy	18,800	$4.04	$75,952.00	6,094,761
9/27/2022	Summer Road Llc	Major Shareholder	Buy	130,000	$4.68	$608,400.00	6,074,761
2/23/2022	Summer Road Llc	Major Shareholder	Buy	10,000	$4.80	$48,000.00
2/18/2022	Summer Road Llc	Major Shareholder	Buy	40,000	$5.00	$200,000.00
1/27/2022	Summer Road Llc	Major Shareholder	Buy	1,477	$5.20	$7,680.40
1/24/2022	Summer Road Llc	Major Shareholder	Buy	44,400	$5.31	$235,764.00
1/20/2022	Summer Road Llc	Major Shareholder	Buy	17,948	$5.70	$102,303.60
1/18/2022	Summer Road Llc	Major Shareholder	Buy	6,807	$6.00	$40,842.00
1/13/2022	Summer Road Llc	Major Shareholder	Buy	10,000	$6.20	$62,000.00
12/15/2021	Summer Road Llc	Major Shareholder	Buy	15,000	$6.22	$93,300.00
12/13/2021	Summer Road Llc	Major Shareholder	Buy	10,510	$6.50	$68,315.00
12/10/2021	Summer Road Llc	Major Shareholder	Buy	30,000	$6.65	$199,500.00
12/8/2021	Summer Road Llc	Major Shareholder	Buy	5,300	$6.75	$35,775.00
12/6/2021	Summer Road Llc	Major Shareholder	Buy	55,600	$6.13	$340,828.00
8/20/2021	Antony C. Mattessich	CEO	Buy	5,000	$9.89	$49,450.00	102,900
5/20/2021	Richard L. Lindstrom	Director	Sell	10,000	$14.30	$143,000.00	90,000

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Ocular Therapeutix (NASDAQ:OCUL)

54.42% of Ocular Therapeutix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ocular Therapeutix Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/24/2023	Deutsche Bank AG	35,806	$0.11M	0.0%	+20.0%	0.045%
11/22/2023	Graham Capital Management L.P.	95,363	$0.30M	0.0%	N/A	0.120%
11/16/2023	Tudor Investment Corp Et Al	174,167	$0.55M	0.0%	-13.3%	0.219%
11/15/2023	GSA Capital Partners LLP	233,582	$0.73M	0.1%	+96.4%	0.294%
11/15/2023	Royal Bank of Canada	169,772	$0.53M	0.0%	+2.9%	0.214%
11/15/2023	Sectoral Asset Management Inc.	969,350	$3.04M	0.6%	+20.8%	1.221%
11/15/2023	AQR Capital Management LLC	67,204	$0.21M	0.0%	+59.1%	0.085%
11/14/2023	California State Teachers Retirement System	17,220	$54K	0.0%	-33.7%	0.022%
11/14/2023	Profund Advisors LLC	20,827	$65K	0.0%	+94.1%	0.026%
11/13/2023	Algert Global LLC	25,480	$80K	0.0%	-48.2%	0.032%
11/13/2023	Northern Trust Corp	673,736	$2.12M	0.0%	+1.7%	0.848%
11/13/2023	Paradigm Capital Management Inc. NY	80,000	$0.25M	0.0%	+100.0%	0.101%
11/13/2023	Invesco Ltd.	249,939	$0.79M	0.0%	+40.0%	0.315%
11/13/2023	FMR LLC	68,780	$0.22M	0.0%	+1,048.8%	0.087%
11/13/2023	Rafferty Asset Management LLC	11,837	$37K	0.0%	N/A	0.015%
11/9/2023	Rhumbline Advisers	130,016	$0.41M	0.0%	+6.4%	0.164%
11/9/2023	Deutsche Bank AG	35,806	$0.11M	0.0%	+20.0%	0.045%
11/9/2023	Citigroup Inc.	20,132	$63K	0.0%	-44.3%	0.025%
11/9/2023	UBS Group AG	53,574	$0.17M	0.0%	-58.8%	0.067%
11/7/2023	New York State Common Retirement Fund	31,521	$99K	0.0%	+229.0%	0.040%
11/7/2023	Barclays PLC	25,963	$81K	0.0%	+22.9%	0.033%
10/31/2023	Levin Capital Strategies L.P.	22,500	$71K	0.0%	-30.8%	0.028%
10/26/2023	Emerald Advisers LLC	20,768	$65K	0.0%	-54.6%	0.026%
10/24/2023	Bank of New York Mellon Corp	240,310	$0.76M	0.0%	-18.1%	0.303%
10/24/2023	Raymond James Financial Services Advisors Inc.	74,401	$0.23M	0.0%	+46.6%	0.094%
10/24/2023	Raymond James & Associates	120,561	$0.38M	0.0%	+155.2%	0.152%
10/23/2023	Deltec Asset Management LLC	2,061,797	$6.47M	1.5%	+4.4%	2.597%
10/13/2023	SG Americas Securities LLC	12,242	$38K	0.0%	N/A	0.015%
9/21/2023	Barclays PLC	21,123	$0.11M	0.0%	-92.4%	0.027%
8/21/2023	California State Teachers Retirement System	25,960	$0.13M	0.0%	-9.4%	0.033%
8/18/2023	Legato Capital Management LLC	116,389	$0.60M	0.1%	N/A	0.147%
8/17/2023	Coastal Bridge Advisors LLC	10,900	$56K	0.0%	N/A	0.014%
8/15/2023	Alliancebernstein L.P.	88,600	$0.46M	0.0%	-5.2%	0.112%
8/15/2023	Wells Fargo & Company MN	34,513	$0.18M	0.0%	+94.0%	0.043%
8/15/2023	Walleye Capital LLC	43,665	$0.23M	0.0%	+132.1%	0.055%
8/15/2023	Goldman Sachs Group Inc.	207,492	$1.07M	0.0%	+14.8%	0.261%
8/15/2023	Royal Bank of Canada	165,055	$0.85M	0.0%	-10.4%	0.208%
8/15/2023	Boothbay Fund Management LLC	17,880	$92K	0.0%	-50.0%	0.023%
8/15/2023	Banco Santander S.A.	397,443	$2.05M	0.0%	+48.4%	0.501%
8/15/2023	Bayesian Capital Management LP	37,400	$0.19M	0.0%	N/A	0.047%
8/14/2023	Cormorant Asset Management LP	645,000	$3.33M	0.2%	N/A	0.812%
8/14/2023	Tudor Investment Corp Et Al	200,843	$1.04M	0.0%	+193.7%	0.253%
8/14/2023	Marshall Wace LLP	15,149	$78K	0.0%	N/A	0.019%
8/14/2023	State Street Corp	1,576,213	$8.13M	0.0%	+5.6%	1.985%
8/14/2023	Nuveen Asset Management LLC	919,602	$4.75M	0.0%	+376.4%	1.158%
8/11/2023	Renaissance Technologies LLC	24,893	$0.13M	0.0%	-65.0%	0.031%
8/11/2023	BlackRock Inc.	5,262,920	$27.16M	0.0%	+7.0%	6.629%
8/11/2023	Harvest Investment Services LLC	61,960	$0.32M	0.2%	N/A	0.078%
8/11/2023	Sectoral Asset Management Inc.	802,680	$4.14M	0.7%	N/A	1.011%
8/11/2023	Geode Capital Management LLC	1,569,904	$8.10M	0.0%	+7.7%	1.977%
8/11/2023	Northern Trust Corp	662,510	$3.42M	0.0%	+0.8%	0.835%
8/10/2023	Profund Advisors LLC	10,728	$55K	0.0%	N/A	0.014%
8/10/2023	Charles Schwab Investment Management Inc.	214,415	$1.11M	0.0%	+4.0%	0.277%
8/10/2023	Citigroup Inc.	36,145	$0.19M	0.0%	+96.2%	0.047%
8/9/2023	BNP Paribas Arbitrage SNC	20,174	$0.10M	0.0%	-58.2%	0.026%
8/8/2023	Rhumbline Advisers	122,223	$0.63M	0.0%	+13.3%	0.158%
8/7/2023	Lincoln National Corp	57,226	$0.30M	0.0%	N/A	0.074%
8/3/2023	Barclays PLC	21,123	$0.11M	0.0%	-92.4%	0.027%
8/3/2023	Mackenzie Financial Corp	44,173	$0.22M	0.0%	-33.0%	0.057%
8/3/2023	Bank of New York Mellon Corp	293,412	$1.51M	0.0%	+1.2%	0.378%
8/2/2023	Bank of Montreal Can	181,509	$0.94M	0.0%	N/A	0.234%
7/31/2023	Levin Capital Strategies L.P.	32,500	$0.17M	0.0%	-84.3%	0.042%
7/31/2023	Strs Ohio	38,200	$0.20M	0.0%	-34.0%	0.049%
7/28/2023	Carson Advisory Inc.	11,852	$0.70M	0.4%	N/A	0.015%
7/27/2023	Virtu Financial LLC	13,383	$69K	0.0%	N/A	0.017%
7/27/2023	Carson Advisory Inc.	11,852	$0.70M	0.6%	N/A	0.015%
7/25/2023	Raymond James Financial Services Advisors Inc.	50,764	$0.26M	0.0%	+244.0%	0.065%
7/25/2023	DekaBank Deutsche Girozentrale	100,000	$0.51M	0.0%	+300.0%	0.129%
7/24/2023	Allspring Global Investments Holdings LLC	15,803	$82K	0.0%	+366.2%	0.020%
7/24/2023	Vontobel Holding Ltd.	10,000	$52K	0.0%	-60.0%	0.013%
7/19/2023	Daymark Wealth Partners LLC	25,000	$0.13M	0.0%	N/A	0.032%
7/18/2023	Deltec Asset Management LLC	1,974,797	$10.19M	2.2%	+3.2%	2.547%
7/18/2023	Allspring Global Investments Holdings LLC	15,803	$82K	0.0%	+366.2%	0.020%
5/26/2023	ProShare Advisors LLC	14,408	$76K	0.0%	-11.5%	0.019%
5/22/2023	Ameriprise Financial Inc.	35,420	$0.19M	0.0%	+16.5%	0.046%
5/18/2023	JPMorgan Chase & Co.	63,941	$0.34M	0.0%	+38.7%	0.082%
5/18/2023	New York State Common Retirement Fund	31,453	$0.17M	0.0%	-41.1%	0.041%
5/16/2023	Jane Street Group LLC	117,046	$0.62M	0.0%	+323.7%	0.151%
5/16/2023	State Street Corp	1,492,959	$7.87M	0.0%	+7.6%	1.926%
5/16/2023	Steward Partners Investment Advisory LLC	6,000	$32K	0.0%	-35.0%	0.008%
5/16/2023	Geode Capital Management LLC	1,457,740	$7.68M	0.0%	+3.3%	1.880%
5/16/2023	Graham Capital Management L.P.	77,661	$0.41M	0.0%	N/A	0.100%
5/16/2023	AQR Capital Management LLC	42,518	$0.22M	0.0%	-62.2%	0.055%
5/16/2023	Balyasny Asset Management L.P.	16,114	$85K	0.0%	-35.5%	0.021%
5/15/2023	Cubist Systematic Strategies LLC	42,989	$0.23M	0.0%	N/A	0.055%
5/15/2023	Two Sigma Advisers LP	309,400	$1.63M	0.0%	-3.8%	0.399%
5/15/2023	Two Sigma Investments LP	323,424	$1.70M	0.0%	+71.0%	0.417%
5/15/2023	Deutsche Bank AG	51,075	$0.27M	0.0%	+46.4%	0.066%
5/15/2023	Price T Rowe Associates Inc. MD	38,295	$0.20M	0.0%	-8.5%	0.049%
5/15/2023	Cetera Investment Advisers	601,150	$3.17M	0.0%	+1.0%	0.775%
5/12/2023	Renaissance Technologies LLC	71,193	$0.38M	0.0%	-75.8%	0.092%
5/12/2023	Aristides Capital LLC	35,000	$0.18M	0.1%	N/A	0.045%
5/12/2023	BlackRock Inc.	4,918,309	$25.92M	0.0%	-0.7%	6.345%
5/12/2023	BNP Paribas Arbitrage SNC	48,231	$0.25M	0.0%	+199.0%	0.062%
5/12/2023	Bank of America Corp DE	66,781	$0.35M	0.0%	-31.9%	0.086%
5/12/2023	Dimensional Fund Advisors LP	24,319	$0.13M	0.0%	-89.6%	0.031%
5/12/2023	Wellington Management Group LLP	307,108	$1.62M	0.0%	-1.9%	0.396%
5/12/2023	Tejara Capital Ltd	72,457	$0.38M	0.2%	-29.3%	0.093%
5/12/2023	ProShare Advisors LLC	14,408	$76K	0.0%	-11.5%	0.019%
5/12/2023	Charles Schwab Investment Management Inc.	206,249	$1.09M	0.0%	+0.8%	0.266%

Data available starting January 2016

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology in the United States. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing OTX-TKI, an axitinib intravitreal implant that is in phase 1 clinical trials for the treatment of wet age-related macular degeneration and other retinal diseases; OTX-TIC, a travoprost intracameral implant, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that has completed phase 2 clinical trials for the treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trials for the short-term treatment of the signs and symptoms of dry eye disease. Ocular Therapeutix, Inc. has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the Company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC, as well as a discovery collaboration with Mosaic Biosciences to identify new targets and therapeutic agents for the treatment of dry age-related macular degeneration (dMAD). The company was incorporated in 2006 and is headquartered in Bedford, Massachusetts.

Today's Range

Now: $2.29

$2.16

$2.30

50 Day Range

MA: $2.64

$2.08

$3.40

52 Week Range

Now: $2.29

$2.00

$7.96

Volume

363,846 shs

Average Volume

1,121,642 shs

Market Capitalization

$181.87 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19

Who are the company insiders with the largest holdings of Ocular Therapeutix?: Ocular Therapeutix's top insider investors include:
Summer Road Llc (Major Shareholder)
Antony C Mattessich (CEO)
Donald Notman (CFO)
Philip C Strassburger (General Counsel)
Rabia Gurses Ozden (Insider)
Christopher G White (Insider)
Learn More about top insider investors at Ocular Therapeutix.
Who are the major institutional investors of Ocular Therapeutix?: Ocular Therapeutix's top institutional investors include:
Deltec Asset Management LLC — 2.60%
Sectoral Asset Management Inc. — 1.22%
Northern Trust Corp — 0.85%
Invesco Ltd. — 0.31%
Bank of New York Mellon Corp — 0.30%
GSA Capital Partners LLP — 0.29%
Learn More about top institutional investors of Ocular Therapeutix stock.
Which major investors are selling Ocular Therapeutix stock?: In the previous quarter, OCUL stock was sold by these institutional investors:
UBS Group AG
Bank of New York Mellon Corp
Tudor Investment Corp Et Al
Emerald Advisers LLC
Algert Global LLC
Citigroup Inc.
Levin Capital Strategies L.P.
California State Teachers Retirement System
Within the last year, company insiders that have sold Ocular Therapeutix company stock include:
Summer Road Llc (Major Shareholder)
Antony C Mattessich (CEO)
Donald Notman (CFO)
Philip C Strassburger (General Counsel)
Rabia Gurses Ozden (Insider)
Learn More investors selling Ocular Therapeutix stock.
Which major investors are buying Ocular Therapeutix stock?: During the previous quarter, OCUL stock was acquired by institutional investors including:
Sectoral Asset Management Inc.
GSA Capital Partners LLP
Graham Capital Management L.P.
Deltec Asset Management LLC
Raymond James & Associates
Invesco Ltd.
FMR LLC
Paradigm Capital Management Inc. NY
During the previous year, these company insiders have bought Ocular Therapeutix stock:
Summer Road Llc (Major Shareholder)
Antony C Mattessich (CEO)
Learn More investors buying Ocular Therapeutix stock.

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

OCUL Insider Trading

Ocular Therapeutix Insider Trading History Chart

Ocular Therapeutix Share Price & Price History

Ocular Therapeutix Insider Trading History

SEC Filings (Institutional Ownership Changes) for Ocular Therapeutix (NASDAQ:OCUL)

Institutional Buying and Selling by Quarter

Ocular Therapeutix Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Ocular Therapeutix?

Who are the major institutional investors of Ocular Therapeutix?

Which major investors are selling Ocular Therapeutix stock?

Which major investors are buying Ocular Therapeutix stock?